Javascript must be enabled to continue!
Abstract 1796: Analysis of TCGA RNASeq data using SpliceSeq provides a survey of alternative splicing in cancer.
View through CrossRef
Abstract
The vast majority of human genes express more than one transcript isoform, and aberrant splicing patterns or changes in isoform expression ratios can lead to disease, notably cancer. Next generation sequencing platforms deliver the finest resolution yet of the transcriptome, and the wealth of sequencing data produced by TCGA provides an excellent basis for a broad study of alternative splicing in cancer. We have developed an interactive, exceptionally user-friendly tool, SpliceSeq, for investigation of alternative splicing in RNASeq data. The program is a follow-up to our SpliceCenter package (http://projects.insilico.us/SpliceCenter/SpliceOverview.jsp), which provides tools for use by the bench biologist in assessing experimental observations that may result from splice variation.
Our results from SpliceSeq for TCGA RNASeq data from several cancer types will be presented. We identify pervasive changes in splicing patterns across different cancer types by comparing tumor vs. normal and clinical subgroups (e.g. tumor stage, hyper-mutator status, and MSI designation). Interesting observations include striking splice variations in APP, the amyloid beta precursor protein, and in PKM, which is centrally involved in the balance between oxidative and glycolytic metabolism in tumors. SpliceSeq is freely available at http://bioinformatics.mdanderson.org/main/SpliceSeq:Overview.
1. Ryan MC, Cleland J, Kim R, Wong WC, Weinstein JN. SpliceSeq: A Resource for Analysis and Visualization of RNA-Seq Data on Alternative Splicing and Its Functional Impacts. Bioinformatics, 10.1093, 2012.
2. Ryan MC, Zeeberg BR, Caplen NJ, Cleland JA, Kahn AB, Liu H, and Weinstein JN. SpliceCenter: a suite of web-based bioinformatic applications for evaluating the impact of alternative splicing on RT-PCR, RNAi, microarray, and peptide-based studies. BMC Bioinformatics 9:313, 2008.
3. Kahn AB, Ryan MC, Liu H, Zeeberg BR, Jamison DC, Weinstein JN. SpliceMiner: a high-throughput database implementation of the NCBI Evidence Viewer for microarray splice variant analysis. BMC Bioinformatics 8:752, 2006.
Supported by NCI Grant No. U24CA143883. The content is solely the responsibility of the authors and does not necessarily represent official views of NCI or NIH. Also supported in part by a gift from the Mary K. Chapman Foundation and a grant from the Michael and Susan Dell Foundation honoring Lorraine Dell.
Citation Format: Michael C. Ryan, John N. Weinstein. Analysis of TCGA RNASeq data using SpliceSeq provides a survey of alternative splicing in cancer. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1796. doi:10.1158/1538-7445.AM2013-1796
American Association for Cancer Research (AACR)
Title: Abstract 1796: Analysis of TCGA RNASeq data using SpliceSeq provides a survey of alternative splicing in cancer.
Description:
Abstract
The vast majority of human genes express more than one transcript isoform, and aberrant splicing patterns or changes in isoform expression ratios can lead to disease, notably cancer.
Next generation sequencing platforms deliver the finest resolution yet of the transcriptome, and the wealth of sequencing data produced by TCGA provides an excellent basis for a broad study of alternative splicing in cancer.
We have developed an interactive, exceptionally user-friendly tool, SpliceSeq, for investigation of alternative splicing in RNASeq data.
The program is a follow-up to our SpliceCenter package (http://projects.
insilico.
us/SpliceCenter/SpliceOverview.
jsp), which provides tools for use by the bench biologist in assessing experimental observations that may result from splice variation.
Our results from SpliceSeq for TCGA RNASeq data from several cancer types will be presented.
We identify pervasive changes in splicing patterns across different cancer types by comparing tumor vs.
normal and clinical subgroups (e.
g.
tumor stage, hyper-mutator status, and MSI designation).
Interesting observations include striking splice variations in APP, the amyloid beta precursor protein, and in PKM, which is centrally involved in the balance between oxidative and glycolytic metabolism in tumors.
SpliceSeq is freely available at http://bioinformatics.
mdanderson.
org/main/SpliceSeq:Overview.
1.
Ryan MC, Cleland J, Kim R, Wong WC, Weinstein JN.
SpliceSeq: A Resource for Analysis and Visualization of RNA-Seq Data on Alternative Splicing and Its Functional Impacts.
Bioinformatics, 10.
1093, 2012.
2.
Ryan MC, Zeeberg BR, Caplen NJ, Cleland JA, Kahn AB, Liu H, and Weinstein JN.
SpliceCenter: a suite of web-based bioinformatic applications for evaluating the impact of alternative splicing on RT-PCR, RNAi, microarray, and peptide-based studies.
BMC Bioinformatics 9:313, 2008.
3.
Kahn AB, Ryan MC, Liu H, Zeeberg BR, Jamison DC, Weinstein JN.
SpliceMiner: a high-throughput database implementation of the NCBI Evidence Viewer for microarray splice variant analysis.
BMC Bioinformatics 8:752, 2006.
Supported by NCI Grant No.
U24CA143883.
The content is solely the responsibility of the authors and does not necessarily represent official views of NCI or NIH.
Also supported in part by a gift from the Mary K.
Chapman Foundation and a grant from the Michael and Susan Dell Foundation honoring Lorraine Dell.
Citation Format: Michael C.
Ryan, John N.
Weinstein.
Analysis of TCGA RNASeq data using SpliceSeq provides a survey of alternative splicing in cancer.
[abstract].
In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC.
Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1796.
doi:10.
1158/1538-7445.
AM2013-1796.
Related Results
Abstract 1423: Integrative analysis predicts lncRNA regulating gene alternative splicing in breast cancer
Abstract 1423: Integrative analysis predicts lncRNA regulating gene alternative splicing in breast cancer
Abstract
Background: Non-coding region occupies 98% of the whole human genome and plays a
regulatory role for protein-coding genes. About 95% of the p...
Abstract 778: Dysregulation of alternative mRNA splicing by oncogenic KRAS in lung adenocarcinoma
Abstract 778: Dysregulation of alternative mRNA splicing by oncogenic KRAS in lung adenocarcinoma
Abstract
Alternative mRNA splicing is dysregulated in many cancers including lung adenocarcinoma. These aberrant splicing events can sometimes be explained by mutati...
Abstract 1289: Crosstalk between methylation and alternative splicing in cancer
Abstract 1289: Crosstalk between methylation and alternative splicing in cancer
Abstract
Background: DNA methylation in promoter regions leads to transcriptional silencing, such as of tumor suppressor genes in cancer. However, the functions of D...
Abstract 1513: Pan-cancer analysis of alternative splicing patterns and association to genomic aberrations
Abstract 1513: Pan-cancer analysis of alternative splicing patterns and association to genomic aberrations
Abstract
Alternative splicing of pre-messenger RNA is responsible for the diversity of transcriptome and proteome, with the majority of multi exon genes producing mu...
Harnessing the genetic diversity engendered by alternative gene splicing
Harnessing the genetic diversity engendered by alternative gene splicing
Our original objectives were to assess the unexplored dimension of alternative splicing as a source of genetic variation. In particular, we sought to initially establish an alterna...
Regulation of Alternative Splicing in B-Cell ALL By DYRK1A
Regulation of Alternative Splicing in B-Cell ALL By DYRK1A
DYRK1A, located in the Down syndrome critical region of chromosome 21, is a serine and threonine kinase that controls multiple cellular processes including apoptosis, cell cycle, t...
HnRNPA2B1 tunes antimycobacterial immune responses in macrophages through alternative splicing of
Irgm1
HnRNPA2B1 tunes antimycobacterial immune responses in macrophages through alternative splicing of
Irgm1
ABSTRACT
Onset and progression of active tuberculosis disease result from upsetting the delicate balance between Mtb virulence and host defenses. Because it dynamic...
CD44 alternative splicing is a sensor of intragenic DNA methylation in tumors
CD44 alternative splicing is a sensor of intragenic DNA methylation in tumors
ABSTRACT
DNA methylation (meDNA) is a suspected modulator of alternative splicing, while splicing in turn is involved in tumour formations nearly as frequently as D...

